Democrats want insulin producers investigated

Insulin producers Novo Nordisk, Sanofi and Eli Lilly have come under attack from Democratic Party representatives in the US who have encouraged the US Federal Trade Commission to investigate them for potential collusion in the US insulin market.

Representative Katie Porter | Photo: Erin Scott/Reuters/Ritzau Scanpix

Six prominent members of the US House of Representatives including Katie Porter, who has previously been committed to regulating the pharmaceutical industry, have sent a letter to the US Federal Trade Commission (FTC) encouraging this authority to investigate Novo Nordisk, Sanofi and Eli Lilly, according to media Endpoints News.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

Further reading

Latest news

See all jobs